Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Database
Language
Publication year range
1.
J Psychiatr Res ; 113: 181-189, 2019 06.
Article in English | MEDLINE | ID: mdl-30981159

ABSTRACT

Studies have suggested the involvement of oxidative stress in the physiopathology of bipolar disorder. Preclinical data have shown that PKC inhibitors may act as mood-stabilizing agents and protect the brain in animal models of mania. The present study aimed to evaluate the effects of Lithium (Li) or tamoxifen (TMX) on behavioral changes and oxidative stress parameters in an animal model of mania induced by ouabain (OUA). Wistar rats received a single intracerebroventricular (ICV) injection of OUA or artificial cerebrospinal fluid (ACSF). From the day following ICV injection, the rats were treated for seven days with intraperitoneal injections of saline, Li or TMX twice a day. On the 7th day after OUA injection, locomotor activity was measured using the open-field test, and the oxidative stress parameters were evaluated in the hippocampus and frontal cortex of rats. The results showed that OUA induced hyperactivity in rats, which is considered a manic-like behavior. Also, OUA increased lipid peroxidation and oxidative damage to proteins, as well as causing alterations to antioxidant enzymes in the frontal cortex and hippocampus of rats. The Li or TMX treatment reversed the manic-like behavior induced by OUA. Besides, Li, but not TMX, reversed the oxidative damage caused by OUA. These results suggest that the manic-like effects induced by OUA and the antimanic effects of TMX seem not to be related to the oxidative stress.


Subject(s)
Antimanic Agents/pharmacology , Bipolar Disorder/drug therapy , Brain/drug effects , Brain/physiopathology , Oxidative Stress , Tamoxifen/pharmacology , Animals , Bipolar Disorder/physiopathology , Disease Models, Animal , Male , Ouabain/administration & dosage , Rats , Rats, Wistar , Selective Estrogen Receptor Modulators/pharmacology
2.
Brain Res Bull ; 134: 228-235, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28802897

ABSTRACT

Lithium (Li) is a mood-stabilizing drug used in the treatment of bipolar disorder (BD). Recently, preclinical studies have demonstrated the potential of tamoxifen (TMX) in the treatment of acute episodes of BD. However, the prolonged use of TMX for mood disorders treatment is controversial. In this study, we evaluated the effects of TMX or Li on cognitive behavior, as well as the levels of neurotrophic factors in the brain of male and female rats. Male and female Wistar rats received administrations of water (control group), TMX or Li via gavage for a period of 28days; the rats were then subjected to the open-field test (to evaluate spontaneous locomotion), and the novel object recognition and step-down inhibitory avoidance tests (to evaluate cognition). The levels of NGF, BDNF and GDNF were evaluated in the hippocampus and frontal cortex of the subject rats. No significant differences were observed in the open-field and inhibitory avoidance tests after drug administration in either the male or female rats. The administration of TMX, but not Li, decreased the recognition index of both the male and female rats in the object recognition test. The chronic administration of TMX decreased, whereas Li increased the levels of BDNF in the hippocampus of both the male and female rats. Tamoxifen decreased the levels of NGF in the hippocampus of female rats. In conclusion, it can be suggested that long-term treatments with TMX can lead to significant cognitive impairments by reducing the levels of neurotrophic factors in the brain of rats.


Subject(s)
Brain/drug effects , Lithium Carbonate/adverse effects , Memory/drug effects , Psychotropic Drugs/adverse effects , Tamoxifen/adverse effects , Animals , Avoidance Learning/drug effects , Avoidance Learning/physiology , Brain/metabolism , Brain-Derived Neurotrophic Factor/metabolism , Cognition/drug effects , Cognition/physiology , Exploratory Behavior/drug effects , Exploratory Behavior/physiology , Female , Glial Cell Line-Derived Neurotrophic Factor/metabolism , Male , Memory/physiology , Memory Disorders/chemically induced , Memory Disorders/metabolism , Motor Activity/drug effects , Motor Activity/physiology , Nerve Growth Factor/metabolism , Random Allocation , Rats, Wistar
3.
Bipolar Disord ; 17(5): 507-17, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25929806

ABSTRACT

OBJECTIVES: Several recent studies have suggested that the physiopathology of bipolar disorder (BD) is related to immune system alterations and inflammation. Lithium (Li) is a mood stabilizer that is considered the first-line treatment for this mood disorder. The goal of the present study was to investigate the effects of Li administration on behavior and cytokine levels [interleukin (IL)-1ß, IL-4, IL-6, IL-10, and tumor necrosis factor-alpha (TNF-α)] in the periphery and brains of rats subjected to an animal model of mania induced by amphetamine (d-AMPH). METHODS: Male Wistar rats were treated with d-AMPH or saline (Sal) for 14 days; on Day 8 of treatment, the rats were administered Li or Sal for the final seven days. Cytokine (IL-1ß, IL-4, IL-6, IL-10, and TNF-α) levels were evaluated in the cerebrospinal fluid (CSF), serum, frontal cortex, striatum, and hippocampus. RESULTS: The present study showed that d-AMPH induced hyperactivity in rats (p < 0.001), and Li treatment reversed this behavioral alteration (p < 0.001). In addition, d-AMPH increased the levels of IL-4, IL-6, IL-10, and TNF-α in the frontal cortex (p < 0.001), striatum (p < 0.001), and serum (p < 0.001), and treatment with Li reversed these cytokine alterations (p < 0.001). CONCLUSIONS: Li modulates peripheral and cerebral cytokine production in an animal model of mania induced by d-AMPH, suggesting that its action on the inflammatory system may contribute to its therapeutic efficacy.


Subject(s)
Antimanic Agents/pharmacology , Behavior, Animal/drug effects , Bipolar Disorder/immunology , Brain/drug effects , Cytokines/drug effects , Lithium Compounds/pharmacology , Motor Activity/drug effects , Animals , Antimanic Agents/therapeutic use , Bipolar Disorder/chemically induced , Bipolar Disorder/drug therapy , Brain/immunology , Central Nervous System Stimulants/toxicity , Cytokines/cerebrospinal fluid , Cytokines/immunology , Dextroamphetamine/toxicity , Disease Models, Animal , Frontal Lobe/drug effects , Frontal Lobe/immunology , Hippocampus/drug effects , Hippocampus/immunology , Hyperkinesis/chemically induced , Hyperkinesis/drug therapy , Hyperkinesis/immunology , Interleukin-10/cerebrospinal fluid , Interleukin-10/immunology , Interleukin-1beta/cerebrospinal fluid , Interleukin-1beta/drug effects , Interleukin-1beta/immunology , Interleukin-4/cerebrospinal fluid , Interleukin-4/immunology , Interleukin-6/cerebrospinal fluid , Interleukin-6/immunology , Lithium Compounds/therapeutic use , Male , Motor Activity/immunology , Neostriatum/drug effects , Neostriatum/immunology , Rats , Rats, Wistar , Tumor Necrosis Factor-alpha/cerebrospinal fluid , Tumor Necrosis Factor-alpha/drug effects , Tumor Necrosis Factor-alpha/immunology
4.
J Psychiatr Res ; 65: 71-9, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25937502

ABSTRACT

Bipolar disorder (BD) is a severe psychiatric disorder associated with social and functional impairment. Some studies have strongly suggested the involvement of oxidative stress in the pathophysiology of BD. Paradoxal sleep deprivation (PSD) in mice has been considered a good animal model of mania because it induces similar manic-like behavior, as well as producing the neurochemical alterations which have been observed in bipolar patients. Thus, the objective of the present study was to evaluate the effects of the antioxidant agent's n-acetylcysteine (Nac) and/or deferoxamine (DFX) on behavior and the oxidative stress parameters in the brains of mice submitted to the animal model of mania induced by PSD. The mice were treated for a period of seven days with saline solution (SAL), Nac, DFX or Nac plus DFX. The animals were subject to the PSD protocol for 36 h. Locomotor activity was then evaluated using the open-field test, and the oxidative stress parameters were subsequently evaluated in the hippocampus and frontal cortex of mice. The results showed PSD induced hyperactivity in mice, which is considered a manic-like behavior. In addition to this, PSD increased lipid peroxidation and oxidative damage to proteins, as well as causing alterations to antioxidant enzymes in the frontal cortex and hippocampus of mice. The Nac plus DFX adjunctive treatment prevented both the manic-like behavior and oxidative damage induced by PSD. Improving our understanding relating to oxidative damage in biomolecules, and the antioxidant mechanisms presented in the animal models of mania are important in helping to improve our knowledge concerning the pathophysiology and development of new therapeutical treatments for BD.


Subject(s)
Acetylcysteine/therapeutic use , Antimanic Agents/therapeutic use , Bipolar Disorder , Brain , Deferoxamine/therapeutic use , Sleep Deprivation/complications , Aldehydes/metabolism , Analysis of Variance , Animals , Bipolar Disorder/drug therapy , Bipolar Disorder/etiology , Bipolar Disorder/pathology , Brain/drug effects , Brain/metabolism , Brain/pathology , Disease Models, Animal , Glutathione Peroxidase/metabolism , Glutathione Reductase/metabolism , Lipid Peroxidation/drug effects , Male , Mice , Mice, Inbred C57BL , Oxidative Stress/drug effects , Tyrosine/analogs & derivatives , Tyrosine/metabolism
5.
J Psychiatr Res ; 61: 114-21, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25467060

ABSTRACT

Bipolar Disorder (BD) is one of the most severe psychiatric disorders. Despite adequate treatment, patients continue to have recurrent mood episodes, residual symptoms, and functional impairment. Some preclinical studies have shown that histone deacetylase inhibitors may act on manic-like behaviors. Neurotrophins have been considered important mediators in the pathophysiology of BD. The present study aims to investigate the effects of lithium (Li), valproate (VPA), and sodium butyrate (SB), an HDAC inhibitor, on BDNF, NGF and GDNF in the brain of rats subjected to an animal model of mania induced by ouabain. Wistar rats received a single ICV injection of ouabain or artificial cerebrospinal fluid. From the day following ICV injection, the rats were treated for 6 days with intraperitoneal injections of saline, Li, VPA or SB twice a day. In the 7th day after ouabain injection, locomotor activity was measured using the open-field test. The BDNF, NGF and GDNF levels were measured in the hippocampus and frontal cortex by sandwich-ELISA. Li, VPA or SB treatments reversed ouabain-related manic-like behavior. Ouabain decreased BDNF, NGF and GDNF levels in hippocampus and frontal cortex of rats. The treatment with Li, VPA or SB reversed these impairment induced by ouabain. In addition, Li, VPA and SB per se increased NGF and GDNF levels in hippocampus of rats. Our data support the notion that neurotrophic factors play a role in BD and in the mechanisms of the action of Li, VPA and SB.


Subject(s)
Antimanic Agents/pharmacology , Bipolar Disorder/drug therapy , Brain-Derived Neurotrophic Factor/metabolism , Butyric Acid/pharmacology , Glial Cell Line-Derived Neurotrophic Factor/metabolism , Locomotion/drug effects , Nerve Growth Factor/metabolism , Affect/drug effects , Animals , Bipolar Disorder/chemically induced , Bipolar Disorder/metabolism , Bipolar Disorder/psychology , Disease Models, Animal , Hippocampus/drug effects , Hippocampus/metabolism , Histamine Antagonists/pharmacology , Lithium Compounds/pharmacology , Male , Motor Activity/drug effects , Ouabain/toxicity , Prefrontal Cortex/drug effects , Prefrontal Cortex/metabolism , Rats , Rats, Wistar , Treatment Outcome , Valproic Acid/pharmacology
6.
Implant Dent ; 21(1): 72-6, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22214989

ABSTRACT

UNLABELLED: STATEMENTS OF PROBLEM: The lack of passivity in implant dentistry may result in failures. Therefore, impression is the first procedure in the fabrication of a passive prosthesis. The aim of this study is to compare the polyvinyl siloxane technique with a resin-splinted transfer copings used for multiple implant abutment impression. METHODS: A master cast was obtained from an edentate ridge. From the master cast, 30 casts were obtained using 3 different impression techniques. Control technique was made with polyvinyl siloxane. Resin-splinted transfer copings in condensation siloxane or irreversible hydrocolloid were used as test. The distances between analogs were obtained using a profile projector. Statistical analysis was carried out using 1-way analysis of variance. RESULTS: No significant difference among the 3 impression techniques (P > 0.05) was observed. CONCLUSION: Resin-splinted transfer copings in condensation siloxane or irreversible hydrocolloid produced impressions as accurately as polyvinyl siloxane.


Subject(s)
Acrylic Resins , Alginates , Dental Abutments , Dental Impression Materials , Dental Impression Technique , Polyvinyls , Siloxanes , Analysis of Variance , Humans , Models, Dental , Polymerization , Reproducibility of Results , Silicon , Statistics, Nonparametric
SELECTION OF CITATIONS
SEARCH DETAIL